RAPGEF6 is a guanine nucleotide exchange factor (GEF) that activates Rap1A, Rap2A, and M-Ras GTPases and mediates mechanotransduction and cellular signaling. The protein functions in mechanosensitive pathways, particularly in relaying extracellular matrix stiffness signals through Rap2 activation to control YAP/TAZ-dependent transcription 1. RAPGEF6 also participates in cell-barrier establishment, microvillus assembly, and neuronal development based on its localization to endocytic vesicles, plasma membrane, and apical regions. In disease contexts, RAPGEF6 has been implicated in schizophrenia pathophysiology; Rapgef6 deletion in mice impairs amygdala function and produces anxiety and memory deficits consistent with schizophrenia-like phenotypes 2. Recent evidence implicates RAPGEF6 in sepsis progression, where it regulates inflammation and oxidative stress via NF-κB-mediated necroptosis pathways 3. A novel ETV6::RAPGEF6 fusion has been identified in chr5 eosinophilic leukemia 4, and altered splicing of RAPGEF6 in gastric cancer endothelial cells correlates with poor patient survival 5. Additionally, loss-of-function variants in canine RAPGEF6 confer a 10- to 17-fold increased risk for laryngeal paralysis, suggesting important roles in neurological function 6. These findings position RAPGEF6 as a multifunctional signaling protein relevant to developmental, inflammatory, and neoplastic processes.